113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03236662 (ClinicalTrials.gov)	November 2016	7/11/2016	(-)- Epicatechin Becker Muscular Dystrophy	UCD0115B: An Open-label Extension Study of Purified Epicatechin to Improve Mitochondrial Function, S ...	Becker Muscular Dystrophy	Drug: (-)-Epicatechin	Craig McDonald, MD	Cardero Therapeutics, Inc.	Completed	18 Years	70 Years	Male	2	Phase 2	United States
2	NCT01856868 (ClinicalTrials.gov)	May 2013	9/5/2013	Use of (-)-Epicatechin in the Treatment of Becker Muscular Dystrophy (Pilot Study)	An Open-label Pilot Study of Purified Tea-derived Epicatechin to Improve Mitochondrial Function, Str ...	Becker Muscular Dystrophy	Drug: (-)-epicatechin	Craig McDonald, MD	Cardero Therapeutics, Inc.	Completed	18 Years	60 Years	Male	7	Phase 1/Phase 2	United States

First Previous1Next Last